Coronary Stent Market Size To Reach $15.2 Billion By 2024: Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to report published by Grand View Research, global coronary stent market is expected to reach USD 15.2 billion by 2024, Increasing burden of cardiovascular diseases (CVDs), including coronary artery diseases, are anticipated to boost the usage of coronary stents.

The coronary stent market is expected to reach USD 15.2 billion by 2024, according to the new report by Grand View Research, Inc. Increasing burden of cardiovascular diseases (CVDs), including coronary artery diseases, are anticipated to boost the usage of coronary stents.

According to the World Health Organization, CVDs contribute to the maximum number of deaths globally. In 2012, approximately 17.5 million deaths were reported from CVDs, representing 31% of the global death statistics. Of the 17.5 million deaths reported, 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Individuals above 60 years of age form the key target population for these products. This demographic is characterized with low immunity levels and is prone to chronic diseases, including CVDs, which thereby serves as a high impact rendering driver for the growth of this industry over the forecast period. As a result, the latest treatments available in cardiac care are expected to increase the life span of the elderly population subset.

The coronary stent market is driven by reimbursement coverage provided by the Center for Medicare & Medicaid Services and private payers. The coverage is availed under national coverage scheme, which covers the product as well as the surgical procedure. The providers require completing certain conditions for coverage-all facilities performing CAS procedures should be certified by CMS.

Browse full research report with TOC on “Coronary Stent Market Analysis by Product (Bare Metal Stents, Drug-Eluting Stents, Bioresorbable Vascular Scaffold) and Segment Forecasts to 2024” at:

Global coronary stent market, 2014 – 2024 (USD Million)

Global coronary stent market, 2014 - 2024 (USD Million)

Further Key Findings From the Study Suggest:

  • The coronary stent market is segmented on the basis of products: Bare Metal Stents, Drug Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS).

  • DES held a lucrative share in 2015, which includes biodegradable and nonbiodegradable stents. Associated benefits such as avoidance of complications, ease of procedures, and comfort to the patient are responsible for the increased usage rates.

  • BVS is anticipated to be on forefront over the forecast period. With launch of first ever BVS in 2016, these products are likely to grow swiftly over the forecast period. BVS has added advantages of restoring vasomotor function, expanding future treatment options, and helping avoid future complications from occurring in permanent devices.

  • North America, especially the U.S., with its sophisticated healthcare system, well-planned reimbursement program, high healthcare expenditure, and large pool of target population held a substantial share in global coronary stents market.

  • Asia Pacific is anticipated to exhibit lucrative growth over the forecast period. Economic developments and government reforms, especially in countries like India and China, are supporting growth of this region. For instance, in India, the introduction of Goods and Services Tax (GST), a comprehensive tax system that avoids cascading tax effects, is helping both consumers and manufacturers save tax. This is anticipated to improve ease of doing business. Such initiatives open investment opportunities for market players in this region.

  • Some key players in the market include Abbott; Boston Scientific Corporation; Medtronic; B. Braun Melsungen AG; Terumo Corporation; Biotronik SE & Co. KG: Stentys SA; MicroPort Scientific Corporation; C. R. Bard, Inc.; and Cook Medical.

  • The market is oligopolistic in nature with few players at the top having similar share. However, recent activities by leading market players are opening avenues for emerging players in this vertical. For instance, loss of market share by Johnson and Johnson’s product “Cypher” and discontinuation of its drug-eluting stent “Nevo” helped other players increase market penetration.

View more reports of this category by Grand View Research at:

Grand View Research has segmented the coronary stent market on the basis of product:

Global Coronary Stents Product Outlook (Revenue, USD Million, 2013 – 2024)

  • Bare Metal Stents (BMS)

  • Drug Eluting Stents

    • Biodegradable

    • Non-Biodegradable

  • Bioabsorbable Vascular Scaffold (BVS)

Coronary Stents Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

Read Our Blogs –

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more  

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States